Connect with us

Business

Cardiff-based medtech business MeOmics Precision Medicine in funding round boost

Published

on

Business Live

MeOmics Precision Medicine began in 2021 as a spin-out from Cardiff University

left to right: Sara Boltman, Women Angels of Wales; Lucy Sykes, MeOmics; Carol Hall, Development Bank of Wales.(Image: Matthew Horwood)

Cardiff-based medtech business MeOmics Precision Medicine is expanding after a joint investment in a £300,000 round from Angels Invest Wales and Women Angels of Wales. The latest investment will allow the company toadvance platform development and data generation, and hire new technical staff.

MeOmics Precision Medicine began in 2021 as a spin-out from Cardiff University, backed by an Innovate UK grant and support from partners St Andrew’s Healthcare. It uses stem cell-based techniques to identify patients’ biological types when conducting drug discovery testing for conditions such as schizophrenia.

READ MORE: Admiral invests in fund backing growth of UK mid-market firmsREAD MORE: Data centre and renewable investment plans at Global Centre of Rail Excellence site delayed

The tests used by the business allow for more targeted drug development, minimising the risk of failure in the clinic or ineffective treatment selection for patients.

Advertisement

The business has received £125,000 in equity investment from Women Angels of Wales – led by data expert and lead investor Sara Boltman – plus £125,000 in match funding from the Wales Angel Co-Investment Fund and £50,000 from existing investors. It also follows a £25,000 grant from the Welsh Government, via Smart Flexible Innovation Support (SFIS)

Lucy Sykes, chief executive of MeOmics Precision Medicine, said: “The complexity of mental illnesses means it is difficult to develop new therapies that will work for everyone. Incorrectly applied treatment for mental illnesses can lead to debilitating side-effects for the individual patient, while also resulting in huge costs to the NHS.

“Our technology allows us to do in psychiatry what’s been done in oncology, and help drug developers to match their treatments not just across broad patient populations, but instead to targeted groups of patients depending on their underlying biology.”

She added: “This investment from Angels Invest Wales and Women Angels of Wales will help us optimise our platform for customers, expand our partnerships and grow our team, as we take the next step in our journey to commercialisation.”

Advertisement

Sara Boltman, Women Angels of Wales, said: “I’ve made a number of smaller investments in the past, but this is the first investment on which I’ve led. As someone with a background in data, I was interested in the work being done by Lucy and the team at MeOmics, and I was glad of the opportunity for us to support another female founder.”

Carol Hall, Co-Investment network manager at the Development Bank of Wales, said: “MeOmics Precision Medicine is an excellent example of the kind of businesses working in Wales’ medtech ecosystem. We were glad to back Women Angels of Wales’ investment in the business, and welcome Sara Boltman’s expertise as lead investor.”

Established to help support women in the early-stage investment community in Wales, Women Angels of Wales is jointly supported by the British Business Bank and the Development Bank of Wales. The syndicate has access to co-investment of up to £350,000 for each deal from the Development Bank’s £8 million Wales Angel Co-Investment Fund.

Advertisement
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Business

Looking At Kyndryl After A 50%+ Drop

Published

on

Looking At Kyndryl After A 50%+ Drop

Looking At Kyndryl After A 50%+ Drop

Continue Reading

Business

Consensus Cloud Solutions, Inc. (CCSI) Q4 2025 Earnings Call Transcript

Published

on

OneWater Marine Inc. (ONEW) Q1 2026 Earnings Call Transcript

Q4: 2026-02-10 Earnings Summary

EPS of $1.41 beats by $0.11

 | Revenue of $87.07M (0.10% Y/Y) beats by $448.16K

Consensus Cloud Solutions, Inc. (CCSI) Q4 2025 Earnings Call February 10, 2026 8:30 AM EST

Company Participants

Adam Varon – Senior Vice President of Finance
R. Turicchi – CEO & Director
Johnny Hecker – Chief Revenue Officer & Executive VP of Operations
James Malone – CFO & Principal Accounting Officer

Advertisement

Conference Call Participants

David Larsen – BTIG, LLC, Research Division
Gene Mannheimer
Isaac Sellhausen – Oppenheimer & Co. Inc., Research Division

Advertisement

Presentation

Operator

Good day, ladies and gentlemen, and welcome to Consensus Q4 2025 Earnings Call. My name is Paul, and I will be the operator assisting you today. [Operator Instructions]

On this call from Consensus will be Scott Turicchi, CEO; Jim Malone, CFO; Johnny Hecker, CRO and Executive Vice President of Operations; and Adam Varon, Senior Vice President of Finance. I will now turn the call over to Adam Varon, Senior Vice President of Finance at Consensus. Thank you. You may begin.

Advertisement

Adam Varon
Senior Vice President of Finance

Good morning, and welcome to the Consensus investor call to discuss our Q4 and year-end 2025 financial results, other key information and our 2026 full year and Q1 2026 guidance. Joining me today are Scott Turicchi, CEO; Johnny Hecker, CRO and EVP of Operations; and Jim Malone, CFO. The earnings call will begin with Scott providing opening remarks. Johnny will give an update on operational progress since our Q3 2025 investor call, and then Jim will discuss Q4 2025 and full year 2025 financial results, then provide our full year 2026 and Q1 2026 guidance range.

After we finish our prepared remarks, we will conduct a Q&A session. At that time, the operator will instruct you on the procedures for asking a question. Before we begin our prepared remarks, allow me to direct you to our forward-looking statements and risk factors on Slide 2 of our investor presentation.

Advertisement
Continue Reading

Business

Middlefield Banc earnings missed by $0.27, revenue fell short of estimates

Published

on


Middlefield Banc earnings missed by $0.27, revenue fell short of estimates

Continue Reading

Business

Pegasystems shares fall 5% as net income declines YoY, despite better-than-expected Q4

Published

on


Pegasystems shares fall 5% as net income declines YoY, despite better-than-expected Q4

Continue Reading

Business

Tyson Foods sees long road before Beef business recovers

Published

on

Tyson Foods sees long road before Beef business recovers

The US cattle herd is the smallest since 1951. 

Continue Reading

Business

Wrapped helps Spotify add users despite artists criticism over fees

Published

on

Wrapped helps Spotify add users despite artists criticism over fees

It highlighted its “Spotify Wrapped” feature for engaging users.

“Our 11th annual Wrapped was bigger, bolder and more layered than ever, celebrating fans, artists, creators and authors around the world,” it said in its results. “Wrapped had more than 300 million engaged users and more than 630 million shares on social media globally in 56 languages”.

Chief executive Gustav Söderström said the firm considered itself the research and development department of the music industry, by focussing on new developments in audio, such as adding video to podcasts, and embracing music made by artificial intelligence (AI).

“Our job is to understand new technologies quickly and capture their potential, which we’ve done time and again,” he said. “The entire industry stands to benefit from this [AI] paradigm shift but we believe those who embrace this change and move fast, will benefit the most.”

Advertisement

But the latest revenue figures come as a heated debate continues about how much money artists and songwriters receive in royalties. Various artists boycotted a Spotify party in 2025, and Taylor Swift famously refused to put her work on the platform for three years because the platform didn’t pay enough.

Continue Reading

Business

J&J Snack introduces protein-packed pretzels

Published

on

J&J Snack introduces protein-packed pretzels

First-of-its-kind products part of SuperPretzel brand.

Continue Reading

Business

Who Is Buying UK Shops in 2025

Published

on

With today marking three weeks since Liz Truss was appointed the UK Prime Minister has revealed that despite consumers reduced spending power in the wake of record inflation and the energy crisis, independent retailers are having to rely on the support of consumers and their local community

Physical shops are still very much in demand in the UK.But who is buying shops in 2025?

Read on as we explore who is buying UK shops in 2025.

Big Companies and Investment Funds

New research from BusinessesForSale.com states that big companies may buy multiple shops that have the potential to be financially profitable. And in some cases, they may be willing to invest in one established shop. These buyers include private equity firms, and these groups may be seeking to improve shops through operational overhauls. Often, private equity firms are aiming to see high rental income and shop growth within a set timeframe. They’ll look for business sales in the UK that can meet their financial goals.

New Buyers

Not every shop buyer already has a portfolio of businesses under their belt. New buyers could be individuals making the transition to ownership roles or younger buyers ready to start their journey. New buyers may find it more difficult to secure financing since they don’t have a track record of success. They’ll need to seek out smaller stores, including bakeries or restaurants, that don’t require a lot of major repairs. And new owners will want to make sure they’re clear about lease payments. Not knowing payment terms can lead to unpleasant financial surprises.

Franchisee Buyers

Franchisee buyers run a shop using a known brand and business model. Working within a franchise scenario can reduce stress, as owners won’t need to revamp a business from scratch. Instead, they’ll have an established system that already appeals to customers. Franchisees should expect to pay some fees for this level of convenience. But those costs also afford them training and advertising opportunities provided by the franchise.

Advertisement

Buyouts from Staff Members

It’s not always outside individuals buying shops in the UK. Sometimes, staff members connected to a shop will choose to purchase it as part of an employee buyout. Staff members will be familiar with the nuances of the given business and know many of the internal business strategies. And, as a result, they’ll be positioned well to operate it effectively. Even so, staff members should be prepared to work with landlords and shore up the money needed to pay the lease. All buyers should be prepared for fit-out liabilities and landlord demands, too. For staff, buying a shop from an owner isn’t always as easy as it seems.

Buying UK Shops in 2025

Buying UK shops can be an invigorating and lucrative experience. And the people doing the buying range from established private equity firms to new buyers seeking their first business opportunities. Working within a franchise system can take some pressure off buyers. And staff members with longstanding connections to a shop may have an advantage over new buyers without existing connections. Ultimately, buyers in the UK should survey the options and choose businesses that align with their financial status and goals.

Advertisement
Continue Reading

Business

Nektar Therapeutics (NKTR) Discusses 36-Week Maintenance Results From Phase 2b REZOLVE-AD Study in Atopic Dermatitis – Slideshow

Published

on

OneWater Marine Inc. (ONEW) Q1 2026 Earnings Call Transcript

Nektar Therapeutics (NKTR) Discusses 36-Week Maintenance Results From Phase 2b REZOLVE-AD Study in Atopic Dermatitis – Slideshow

Continue Reading

Business

US consumer spending slowed in December – Is it a warning for the economy?

Published

on

US consumer spending slowed in December - Is it a warning for the economy?

Retail sales were unexpectedly flat in December as consumers pulled back, raising questions about a broader economic slowdown.

Continue Reading

Trending

Copyright © 2025